SI9400291A - Azacyclic-heterocyclic compounds as angiotensin ii receptor antagonists - Google Patents

Azacyclic-heterocyclic compounds as angiotensin ii receptor antagonists Download PDF

Info

Publication number
SI9400291A
SI9400291A SI9400291A SI9400291A SI9400291A SI 9400291 A SI9400291 A SI 9400291A SI 9400291 A SI9400291 A SI 9400291A SI 9400291 A SI9400291 A SI 9400291A SI 9400291 A SI9400291 A SI 9400291A
Authority
SI
Slovenia
Prior art keywords
alkyl
carboxylic acid
group
pyridin
substituents
Prior art date
Application number
SI9400291A
Other languages
English (en)
Slovenian (sl)
Inventor
Philip A Carpino
Eric R Larson
Banavara L Mylari
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SI9400291A publication Critical patent/SI9400291A/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SI9400291A 1993-07-15 1994-07-14 Azacyclic-heterocyclic compounds as angiotensin ii receptor antagonists SI9400291A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9234993A 1993-07-15 1993-07-15

Publications (1)

Publication Number Publication Date
SI9400291A true SI9400291A (en) 1995-10-31

Family

ID=22232802

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9400291A SI9400291A (en) 1993-07-15 1994-07-14 Azacyclic-heterocyclic compounds as angiotensin ii receptor antagonists

Country Status (8)

Country Link
US (1) US5789415A (fr)
AP (1) AP9400651A0 (fr)
AU (1) AU6979494A (fr)
FI (1) FI943359A (fr)
IL (1) IL110239A0 (fr)
MA (1) MA23268A1 (fr)
SI (1) SI9400291A (fr)
WO (1) WO1995002596A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003059884A1 (fr) 2001-12-21 2003-07-24 X-Ceptor Therapeutics, Inc. Modulateurs de lxr
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
JP4866723B2 (ja) * 2004-02-26 2012-02-01 協和発酵キリン株式会社 好中球性炎症疾患の予防及び/または治療剤
EP1830869B1 (fr) 2004-12-24 2013-05-22 Spinifex Pharmaceuticals Pty Ltd Procede de traitement ou prophylaxie
AU2007229322B2 (en) 2006-03-20 2012-04-05 Novartis Ag Method of treatment or prophylaxis inflammatory pain
US7828840B2 (en) * 2007-11-15 2010-11-09 Med Institute, Inc. Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists
US9394290B2 (en) * 2010-10-21 2016-07-19 Universitaet Des Saarlandes Campus Saarbruecken Selective CYP11B1 inhibitors for the treatment of cortisol dependent diseases

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240928A (en) * 1989-07-03 1993-08-31 Merck & Co., Inc. Substituted quinazolinones as angiotensin II antagonists
JPH05504969A (ja) * 1990-02-13 1993-07-29 メルク・エンド・カムパニー・インコーポレーテツド 置換ベンジル要素を含有するアンギオテンシン2アンタゴニスト類
US5177074A (en) * 1991-03-26 1993-01-05 Merck & Co., Inc. Angiotensin ii antagonists incorporating a substituted thiophene or furan
US5151435A (en) * 1991-04-08 1992-09-29 Merck & Co., Inc. Angiotensin ii antagonists incorporating an indole or dihydroindole
DE4200954A1 (de) * 1991-04-26 1992-10-29 Bayer Ag Heterocyclisch substituierte phenylessigsaeurederivate
GB9113628D0 (en) * 1991-06-25 1991-08-14 Ici Plc Heterocyclic derivatives
GB9113626D0 (en) * 1991-06-25 1991-08-14 Ici Plc Heterocyclic compounds
IL102183A (en) * 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them
US5187159A (en) * 1991-10-07 1993-02-16 Merck & Co., Inc. Angiotensin II antagonists incorporating a substituted 1,3-benzodioxole or 1,3-benzodithiole
US5283242A (en) * 1991-10-24 1994-02-01 American Home Products Corporation Substituted benzimidazoles and quinazolines as antihypertensives
US5350752A (en) * 1991-12-16 1994-09-27 E. R. Squibb & Sons, Inc. Dihydropyrimidine derivatives
US5308853A (en) * 1991-12-20 1994-05-03 Warner-Lambert Company Substituted-5-methylidene hydantoins with AT1 receptor antagonist properties
US5300668A (en) * 1993-03-10 1994-04-05 Pfizer Inc. Certain esters of 1-(4-X-methylphenyl)cyclopent-3-ene-1-carboxylic acid, wherein X is a trialkylsilyloxy, bromo or hydroxy group, as intermediates

Also Published As

Publication number Publication date
FI943359A (fi) 1995-01-16
IL110239A0 (en) 1994-10-21
WO1995002596A1 (fr) 1995-01-26
US5789415A (en) 1998-08-04
AP9400651A0 (en) 1995-12-30
MA23268A1 (fr) 1995-04-01
AU6979494A (en) 1995-02-13
FI943359A0 (fi) 1994-07-14

Similar Documents

Publication Publication Date Title
US10000489B2 (en) Compounds αvβ6 integrin antagonists
EP2311825B1 (fr) Pyrimidineamines en tant que modulateurs de l'angiogénèse
US20110105509A1 (en) Indole based receptor crth2 antagonists
KR101433745B1 (ko) 5-ht6 길항제로서의 설포닐피라졸린 카복사미딘 유도체
JP2007519694A (ja) P38キナーゼ阻害剤
WO2001098301A1 (fr) Composes de pyrazolopyridine et utilisation de ces derniers en tant que medicaments
BRPI0808888A2 (pt) Composto de fenil amino pirimidina e seus usos
US20100016307A1 (en) Novel compounds
BR112021013557A2 (pt) Amidas de pirrolidina substituídas iii
DE69704060T2 (de) Tetrahydroisochinolinderivate und ihre pharmazeutische anwendung
WO2004016605A1 (fr) Derives de 2-aminopyrimidine utilises en tant qu'antagonistes des recepteurs a2a et a1 de l'adenosine
SI9400291A (en) Azacyclic-heterocyclic compounds as angiotensin ii receptor antagonists
PT88614B (pt) Processo para a preparacao de antagonistas do factor activador de plaquetas di-hidropiridinicos
DE60318874T2 (de) Pyrazolderivate
DE69204920T2 (de) Angiotensin-II-Antagoniste.
HUT64343A (en) Methods for producing beta-carboline derivatives and pharmaceutical preparatives containing them as active agent
US20060030601A1 (en) Novel aminopyridine derivatives as mGluR5 antagonists
GB2572526A (en) Heterocyclic small molecule modulators of human STING
US20170305915A1 (en) Indazole and indole derivatives as inhibitors of retinoic acid relates orphan receptor gamma (ror gamma) for the treatment of immune-related diseases
DE60103752T2 (de) Verfahren zur herstellung von pyrazolopyridinderivaten
CN114853723B (zh) 吲哚类化合物btk抑制剂的制备及其应用
DE60319254T2 (de) Pyrazolamide zur behandlung von hiv-infektionen
KR20040034996A (ko) 리스페리돈의 개선된 제조방법
US20080132699A1 (en) Process For the Preparation of Diazine Derivatives
EP1022270A1 (fr) Derives de pirazole